Tags

Type your tag names separated by a space and hit enter

[Menstrual migraine].
Rev Prat. 1990 Feb 11; 40(5):395-8.RP

Abstract

The cyclic fall in oestrogen level associated with the beginning of menstruations produces common migraine in 10 to 20 p. 100 of women in the general population. In women who already have migraine, the menstruations coincide with triggering or worsening of the attacks in 60 p. 100 of the cases. About 1 out of 10 women who do not have spontaneous menstrual migraine begin to suffer regularly as soon as they take an oral combination contraceptive. High doses of antigonadrotropic progestogens make the attacks worse because they herald or enhance the hypoestrogenaemia. Insufficient doses of oestrogens administered orally induce brief daily episodes of increased, then decreased oestrogenic stimulation, and they also facilitate the occurrence of migrainous attacks. The best available preventive treatment consists of cyclic percutaneous administration of oestradiol in doses that are sufficient to stabilize blood oestradiol levels at 60-80 pg/ml during the critical week. This treatment is the only one that prevents migrainous attacks and preserves the menstrual cycle. Obviously, it only benefits women with menstrual migraine, and fluctuations in oestradiolaemia are only one of the multiple precipitating factors of migrainous attacks.

Authors+Show Affiliations

Service endocrinologie et médecine de la reproduction, hôpital Necker, Paris.

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

2309069

Citation

de Lignières, B. "[Menstrual Migraine]." La Revue Du Praticien, vol. 40, no. 5, 1990, pp. 395-8.
de Lignières B. [Menstrual migraine]. Rev Prat. 1990;40(5):395-8.
de Lignières, B. (1990). [Menstrual migraine]. La Revue Du Praticien, 40(5), 395-8.
de Lignières B. [Menstrual Migraine]. Rev Prat. 1990 Feb 11;40(5):395-8. PubMed PMID: 2309069.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Menstrual migraine]. A1 - de Lignières,B, PY - 1990/2/11/pubmed PY - 1990/2/11/medline PY - 1990/2/11/entrez SP - 395 EP - 8 JF - La Revue du praticien JO - Rev Prat VL - 40 IS - 5 N2 - The cyclic fall in oestrogen level associated with the beginning of menstruations produces common migraine in 10 to 20 p. 100 of women in the general population. In women who already have migraine, the menstruations coincide with triggering or worsening of the attacks in 60 p. 100 of the cases. About 1 out of 10 women who do not have spontaneous menstrual migraine begin to suffer regularly as soon as they take an oral combination contraceptive. High doses of antigonadrotropic progestogens make the attacks worse because they herald or enhance the hypoestrogenaemia. Insufficient doses of oestrogens administered orally induce brief daily episodes of increased, then decreased oestrogenic stimulation, and they also facilitate the occurrence of migrainous attacks. The best available preventive treatment consists of cyclic percutaneous administration of oestradiol in doses that are sufficient to stabilize blood oestradiol levels at 60-80 pg/ml during the critical week. This treatment is the only one that prevents migrainous attacks and preserves the menstrual cycle. Obviously, it only benefits women with menstrual migraine, and fluctuations in oestradiolaemia are only one of the multiple precipitating factors of migrainous attacks. SN - 0035-2640 UR - https://www.unboundmedicine.com/medline/citation/2309069/[Menstrual_migraine]_ L2 - https://www.diseaseinfosearch.org/result/4811 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.